Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Kazia Therapeutics Limited - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kazia Therapeutics Limited - ADR market cap is $7.74M.
What is the 52-week high for Kazia Therapeutics Limited - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kazia Therapeutics Limited - ADR 52 week high is $39.05 as of September 13, 2025.
What is the 52-week low for Kazia Therapeutics Limited - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kazia Therapeutics Limited - ADR 52 week low is $2.86 as of September 13, 2025.
What is Kazia Therapeutics Limited - ADR stock price today?
Kazia Therapeutics Limited - ADR stock price today is $8.00.
What was Kazia Therapeutics Limited - ADR stock price yesterday?
Kazia Therapeutics Limited - ADR stock price yesterday was $8.15.
What is the PE ratio of Kazia Therapeutics Limited - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kazia Therapeutics Limited - ADR’s P/E ratio is -0.27.
What is the Price-to-Book ratio of Kazia Therapeutics Limited - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kazia Therapeutics Limited - ADR P/B ratio is -3.2817.
What is the 50-day moving average of Kazia Therapeutics Limited - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kazia Therapeutics Limited - ADR 50-day moving average is $8.52.
KZIA Kazia Therapeutics